Nov 14, 2:00 – 4:00 AM (UTC)
2890 Kilgore Rd, 2890 Kilgore Road, Rancho Cordova, 95670
Cell and gene therapy is revolutionizing disease treatment by providing targeted approaches and manufacturers are enhancing and scaling up automated, closed systems with integrated software controls to meet regulatory standards, reduce costs, and ensure consistent production, minimizing contamination risks.
Get tickets
The Sacramento Region is home to a vibrant medical startup ecosystem. To support its growth, MedStart, is a program dedicated to fostering innovation in medical and life sciences.
This month, Mary Ann F. Santos, Thermo Fisher Scientific Senior Manager, Strategic Collaborations and Sarah Daoudi and Kevin Pridham, Field Applications Scientists for Cell and Gene Therapy and Genome Engineering will be discussing process optimization for efficient cell and gene therapy manufacturing.
Cell and gene therapy is transforming the treatment of diseases by providing a targeted approach that has led to prolonged success for many patients. With a growing number of therapies in development, manufacturers are seeking ways to enhance and scale up the manufacturing process to meet regulatory standards and reduce costs.
For cell therapies, one strategy to overcome current manufacturing challenges is utilizing automated, closed systems with integrated software controls. The same can apply for streamlining gene therapies and utilizing optimized systems that allow for seamless scale-up of viral production. For the manufacture of cell therapies requiring gene modification, access to GMP-grade nucleases & reagents that can meet your clinical needs and required regulatory standards is also critical.
These systems offer advantages over traditional open systems, such as standardized processes, cost savings, consistent production results, and reduced contamination risks. This presentation will highlight some of the current challenges in cell and gene therapy manufacturing, highlighting the benefits of new closed, automated, and modular technologies in facilitating both end-to-end viral and non-viral processes. Additionally, we will explore the development of a High Fidelity GMP Cas9 protein that can be implemented within these closed, automated, and modular cell manufacturing systems.
MedStart is supported by ReadyStart Cleanroom, Carlsen Center for Innovation and Entrepreneurship, the 50 Economic Alliance, and Startup Folsom.
Please note that this event is in-person at the ReadyStart CleanRooms.This month,
Thermo Fisher Scientific
Global Cell and Gene Therapy Senior Manager
Thermo Fisher Scientific
Staff Scientist, Field Application Scientist, Cell and Gene Therapy
Thermo Fisher Scientific
Field Applications Scientist
Thursday, November 14, 2024
2:00 AM – 4:00 AM (UTC)
| Networking |
| Presentation |
This is Startup Grind. We are the world’s largest startup community.
Our Mission
To give startups everywhere the education and opportunities they need to build, grow, and scale their companies.
Our Values
We believe in making friends, not contacts. We believe in giving first, not taking. We believe in helping others before helping yourself.
Tools & Discounts for Startups
Take advantage of resources and offers provided by organizations we know and love, designed to help you navigate the startup journey.
Global Conference
Our annual flagship event in Silicon Valley brings together thousands of startup teams, investors and organizations from all over the world.
Join the Startup Membership
This membership gives you free access to networking, events, mentorship, office hours, and other exclusive opportunities curated by Startup Grind HQ.
